Exogenous and endogenous antioxidants (ROS) in physiology and pathology of the cardiovascular system
Canadian Journal of Physiology and Pharmacology · 01.01.2026 · 104 · 1-12
DOI: 10.1139/cjpp-2025-0240 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.01.2026. Verfasst von Ghassan Bkaily und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada. Hauptthemen laut MEDLINE: Antioxidants, Reactive Oxygen Species, Cardiovascular System, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, NSERC.
Abstract (Originalsprache)
Generation of reactive oxygen species (ROS) is a physiological product of cell activity that is mainly generated by the mitochondria as well as by transmembrane NADPH oxidases (NOX1–5) present at the plasma and nuclear envelope membranes. The level of basal intracellular ROS is regulated by endogenous antioxidants such as glutathione (GSH), and the endogenous and exogenous antioxidant taurine. These two antioxidants are present in all types of cells and more particularly in the heart and the vascular system. They regulate and control intrcellular normal ROS levels in order to prevent an increase that induces dysfunction of the cardiovascular system. There are also exogenous antioxidants that are present in many types of food such as vitamin C, vitamin E, and resveratrol. These exogenous antioxidants are necessary to complement the effect of endogenous antioxidants. However, according to the literature, it is difficult to generalize about the beneficial effect of exogenous antioxidants in preventing cardiovascular disease. This does not necessarily seem to be the case for endogenous antioxidants. In this review, we will discuss the advantages and disadvantages of using exogenous and endogenous antioxidants, and suggest the potential application of one of them.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
ORCID-Profile: Ghassan Bkaily
Förderung
- Canadian Institutes of Health Research
- NSERC
Zitieren
APA
Bkaily, G., Jazzar, A., & Jacques, D. (2026). Exogenous and endogenous antioxidants (ROS) in physiology and pathology of the cardiovascular system. Canadian Journal of Physiology and Pharmacology, 104, 1-12. https://doi.org/10.1139/cjpp-2025-0240
Vancouver
Bkaily G, Jazzar A, Jacques D. Exogenous and endogenous antioxidants (ROS) in physiology and pathology of the cardiovascular system. Canadian Journal of Physiology and Pharmacology. 2026;104:1-12. doi:10.1139/cjpp-2025-0240
BibTeX
@article{Bkaily2026,
author = {Bkaily, Ghassan and Jazzar, Ashley and Jacques, Danielle},
title = {Exogenous and endogenous antioxidants (ROS) in physiology and pathology of the cardiovascular system},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2026},
volume = {104},
pages = {1--12},
doi = {10.1139/cjpp-2025-0240}
}
EUVIMED